Brief: Strides Pharma Science Says Strides Softgels Shall Undertake Acquisition Of CDMO Business And Soft Gelatin Business From Strides Pharma Global
25/09/2023 12:40
Sept 25 (Reuters) - Strides Pharma Science Ltd
SRID.NS :
* STRIDES SOFTGELS SHALL UNDERTAKE ACQUISITION OF CDMO
BUSINESS
AND SOFT GELATIN BUSINESS FROM STRIDES PHARMA GLOBAL
* DEFINITIVE AGREEMENTS SHALL BE EXECUTED WITHIN THREE
MONTHS FROM
DATE OF SIGNING MOU
Source text for Eikon: ID:nBSE7r69kx
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees